FLIXOTIDE

This brand name is authorized in Austria, Australia, Brazil, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Malta, Mexico, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug FLIXOTIDE contains one active pharmaceutical ingredient (API):

1 Fluticasone UNII O2GMZ0LF5W - FLUTICASONE PROPIONATE

Fluticasone has anti-inflammatory and vasoconstrictive features. Fluticasone given by inhalation at recommended doses has a potent glucocorticoid anti-inflammatory action within the lungs, resulting in a reduction of both symptoms and exacerbations of asthma, with a lower incidence and severity of adverse effects than those observed when corticosteroids are administered systemically. Read about Fluticasone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
FLIXOTIDE EVOHALER Pressurised inhalation, suspension	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D07AC17	Fluticasone	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AC Corticosteroids, potent (group III)
Discover more medicines within D07AC17
R01AD08	Fluticasone	R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AD Corticosteroids
Discover more medicines within R01AD08
R03BA05	Fluticasone	R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BA Glucocorticoids
Discover more medicines within R03BA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8147T, 8148W, 8149X, 8345F, 8346G, 8516F
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 510603101177319, 510603102173317, 510603103171318, 510603105121415, 510615040053905, 510615040054005, 510617030056603, 510617030056703
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 27.704-05-07, 27.705-05-07, 29262-06-10
Country: EE	Ravimiamet	Identifier(s): 1007840, 1007862, 1007884, 1130690
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 60477, 60479, 60480, 60482
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 002558, 082685, 082719, 135434, 521047, 521062, 555870
Country: FR	Base de données publique des médicaments	Identifier(s): 61856322, 62933355, 64115257, 65156075, 66545581, 68652265
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 138766, 138768, 138770, 138776, 138779, 142338, 142340, 142342, 142344, 142346, 142348, 142350, 142352, 161797, 161799, 161801, 161803, 161805, 161807, 199651, 28293, 28309, 28314, 31839, 31844, 31850, 31854, 33896, 33994, 374463, 374465, 374467
Country: HK	Department of Health Drug Office	Identifier(s): 38094, 38095, 38096, 45661
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-145522875, HR-H-226045614, HR-H-977557368
Country: IE	Health Products Regulatory Authority	Identifier(s): 24809, 24867, 25640, 25671, 25682, 25694, 26001, 26012, 26024, 26036, 26048, 26135, 26142, 26153
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 3537, 3538, 3539, 3540, 4030, 4031, 4032, 4033, 4784
Country: IT	Agenzia del Farmaco	Identifier(s): 028667095, 028667107
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1000776, 1000777, 1000778, 1000779, 1000781, 1000782, 1003495, 1006996, 1092582
Country: MT	Medicines Authority	Identifier(s): MA192/00401, MA192/00402, MA192/00403, MA192/00404, MA192/00405, PI908/21601A, PI908/21602A, PI908/21603A
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 172M95, 390M99
Country: NG	Registered Drug Product Database	Identifier(s): B4-8511, B4-9147
Country: NL	Z-Index G-Standaard	Identifier(s): 13813455, 13813471, 13813544, 14039311, 14039338, 14039346, 14236680, 14236699
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 106151, 39055, 39063, 39071, 45624, 45632, 51462, 66664
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 5256, 5260, 5267, 5268, 5269, 5270, 8606
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100093955, 100093961, 100099225, 100099231, 100099248, 100109751, 100194751, 100228361, 100233439
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65201001, W65201002, W65204003, W65204004, W65205003, W65205004, W65206001, W65206002, W65207001, W65207002, W65208001, W65208002, W65209001
Country: SG	Health Sciences Authority	Identifier(s): 11112P, 11347P, 11348P, 11358P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 2113071, 5163071
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699522521500, 8699522521517, 8699522523528, 8699522523535, 8699522523603, 8699522523610, 8699522553556, 8699522553563, 8699522553570, 8699522553587, 8699522553594
Country: ZA	Health Products Regulatory Authority	Identifier(s): 30/21.5.1/0068, 30/21.5.1/0069, 30/21.5.1/0070, 30/21.5.1/0071, 32/21.5.1/0082, 32/21.5.1/0083, 35/21.5.1/0377